MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / News Well / Ex-Boston Scientific CEO Tobin joins Oxford Immunotec board | Personnel Moves

Ex-Boston Scientific CEO Tobin joins Oxford Immunotec board | Personnel Moves

December 3, 2014 By Brad Perriello Leave a Comment

Ex-Boston Scientific CEO Tobin joins Oxford Immunotec board | Personnel Moves

Jim Tobin, the former CEO of Boston Scientific (NYSE:BSX) who oversaw the $27 billion acquisition of Guidant Corp. in 2006, joined the board of directors at Oxford Immunotec Global (NSDQ:OXFD), that company said yesterday.

The Oxford, U.K.- and Marlborough, Mass.-based British firm makes diagnostics tests for the immunology field.

"Jim is a highly regarded medical technology executive who will be a great addition to our board," Oxford Immunotec CEO Peter Wrighton-Smith said in prepared remarks. "Jim’s extensive experience in the healthcare industry, both domestic and international, will be invaluable to our Company as we look to further grow our business and drive adoption of our products."

Tobin was CEO at Boston Scientific from 1999 until 2009 and shepherded the company through its acquisition of Guidant, labeled as the 2nd-worst merger in corporate history. BSX shelled out $27 billion in cash and stock for Guidant after a bidding war with Johnson & Johnson (NYSE:JNJ). Repercussions from the Guidant buyout are still reverberating to this day; J&J is seeking a $7.2 billion damages award in a lawsuit filed over its jilting by Guidant.

Tobin also serves on the boards of several other life science firms, including Aptus Endosystems and CardioDx.

 NinePoint Medical puts ex-NeuroTherm CEO von Jako in the corner office
NinePoint Medical Imaging tapped the former CEO of NeuroTherm, acquired by St. Jude Medical last summer for $200 million, to be its new CEO. Von Jako replaces Dr. Charles Carignan, who departed for the top job at prosthetics maker BiOM in July.
Read more

 Symmetry Medical names post-spinout management team
Symmetry Medical (NYSE:SMA) revealed the management team it plans to put in place after it spins out its surgical unit as a stand-alone publicly traded company, saying it also plans to restructure the Symmetry Surgical business to "reduce cost and flatten the organization structure."
Read more

 Orthofix extends deal with extremities head Bianchi

Orthofix (NSDQ:OFIX) said it extended its deal with the president of its extremities fixation business, Davide Bianchi.
Read more

 Lombard Medical taps medtech vet Kullback for CFO

Lombard Medical Technologies (LON:LMT) said it tapped 30-year medtech veteran William Kullback to be its new finance chief, replacing Ian Ardill.
Read more

  • CMS names new ‘data czar’
  • MITA bolsters gov’t relations team with NASS hire
  • NxStage Medical’s accounting chief Hershberger steps down
  • Alere names Cunningham as new investor relations veep
  • Interim execs Bernhardt, Burke leave Echo Therapeutics

Filed Under: News Well Tagged With: Alere, Boston Scientific, Centers for Medicare and Medicaid Services (CMS), Echo Therapeutics Inc., lombardmedical, Medical Imaging & Technology Alliance (MITA), NinePoint Medical Inc., NxStage Medical Inc., Orthofix, Oxford Immunotec, Personnel Moves, Symmetry Medical Inc.

In case you missed it

  • House bill asks CMS to cover breakthrough devices for Medicare patients
  • Empirical Spine completes enrollment in LimiFlex pivotal trial
  • MolecuLight wins FDA clearance for handheld imaging device
  • Medical device tax will cost 20,000 jobs, report says
  • W.L. Gore officials think they can spur insulin delivery system innovation
  • EPA moves closer to stricter regulations on medtech ethylene oxide sterilization
  • 3DBio Therapeutics wins FDA rare pediatric disease designation for outer ear reconstruction
  • CryoLife wins CE Mark for E-nya thoracic stent graft
  • Edwards projects $5 billion in sales for 2020
  • SPR Therapeutics announces 1000th placement of nerve stimulation device
  • The best places to work for medtech sales reps
  • DePuy Synthes issues urgent field safety notice for USS II Polyaxial 3D heads
  • Haemonetics (HAE) launches SafeTrace Tx in North America
  • Vicarious Surgical wins FDA breakthrough designation for surgical robot
  • Natus Medical issues field safety notice for snap electrode leads
  • J&J’s Ethicon gets to substitute 20 new claims on surgical stapler patent
  • Minerva Surgical raises $10m

RSS From Medical Design & Outsourcing

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS